INSIGHTS ON DRUG DEVELOPMENT
-
Simplify Cell Line Development
A streamlined workflow combining microfluidic dispensing and multimodal imaging enables efficient single-cell isolation, viability assessment, and outgrowth analysis to support cell line development.
-
Scale Your Viral Vector Production With A Streamlined Bioreactor System
Scale your viral vector or vaccine production with a streamlined, intermediate-scale bioreactor system that bridges development and commercial manufacturing, supporting applications from exosomes to vaccines.
-
Measuring Thermodynamic Parameters In The Drug Development Process
Join Dr. Ladbury to explore how thermodynamic data can enhance our understanding of protein-ligand interactions and how it is crucial for optimizing drug efficacy and safety in pharmaceutical development.
-
Streamline Drug Development With A Lab Informatics Platform
Learn how a tiered approach to ADME-Tox studies can help researchers navigate early-stage preclinical research and mitigate the risk of costly failures in drug development.
-
Screening For Amorphous Drug Substance5/6/2026
Incorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.
-
How Lipid Nanoparticles Enable Next-Gen Delivery10/20/2025
Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.
-
Advanced Therapies Going Mainstream: Are We There Yet?11/14/2025
Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.
-
How To Choose The Appropriate Filter Material For Every Sample2/24/2026
Membrane compatibility plays a crucial role in reliable sample filtration. Knowing how different filter materials interact helps prevent common workflow issues and supports efficient filtration.
-
Method Development For Forced Degradation Of GLP-1 Agonist3/18/2026
Gain insight into how a systematic approach reveals impurity behavior, strengthens selectivity, and refines chromatographic conditions to build a reliable degradation method for a GLP‑1 agonist.
DRUG DEVELOPMENT SOLUTIONS
-
Our comprehensive network of manufacturing facilities enables us to offer robust supply assurance and consistent product quality to biopharmaceutical developers around the globe.
-
Learn about a manufacturing site with over 35 years of expertise in bioconjugation, APIs, excipients, and adjuvants manufacturing that helps clients accelerate drug development programs worldwide.
-
Explore a diverse range of immunoassays for hormone analysis, neurodegeneration, autoimmunity, and salivary diagnostics—each designed for high sensitivity, reproducibility, and ease of use.
-
3D organoids offer enhanced physiological relevance and are ready to use from cryopreserved vials. Discover how they can streamline your research with high-quality and comprehensive support.
-
Overcome clinical transition challenges with integrated services, including study design, expert regulatory support, robust recruitment, and flexible manufacturing.